Literature DB >> 24700991

Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa.

Michelle J Groome1, Sung-Sil Moon2, Daniel Velasquez2, Stephanie Jones1, Anthonet Koen1, Nadia van Niekerk1, Baoming Jiang2, Umesh D Parashar2, Shabir A Madhi1.   

Abstract

OBJECTIVE: To investigate the effect of abstention from breastfeeding, for an hour before and after each vaccination, on the immune responses of infants to two doses of rotavirus vaccine.
METHODS: In Soweto, South Africa, mother-infant pairs who were uninfected with human immunodeficiency virus (HIV) were enrolled as they presented for the "6-week" immunizations of the infants. Each infant was randomly assigned to Group 1 - in which breastfeeding was deferred for at least 1 h before and after each dose of rotavirus vaccine - or Group 2 - in which unrestricted breastfeeding was encouraged. Enzyme-linked immunosorbent assays were used to evaluate the titres of rotavirus-specific IgA in samples of serum collected from each infant immediately before each vaccine dose and 1 month after the second dose. Among the infants, a fourfold or greater increase in titres of rotavirus-specific IgA following vaccination was considered indicative of seroconversion.
FINDINGS: The evaluable infants in Group 1 (n=98) were similar to those in Group 2 (n=106) in their baseline demographic characteristics and their pre-vaccination titres of anti-rotavirus IgA. After the second vaccine doses, geometric mean titres of anti-rotavirus IgA in the sera of Group-1 infants were similar to those in the sera of Group-2 infants (P=0.685) and the frequency of seroconversion in the Group-1 infants was similar to that in the Group-2 infants (P=0.485).
CONCLUSION: Among HIV-uninfected South African infants, abstention from breastfeeding for at least 1 h before and after each vaccination dose had no significant effect on the infants' immune response to a rotavirus vaccine.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24700991      PMCID: PMC3967577          DOI: 10.2471/BLT.13.128066

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  25 in total

1.  Horizontal transmission of a human rotavirus vaccine strain--a randomized, placebo-controlled study in twins.

Authors:  Luis Rivera; Lourdes Mendez Peña; Isabelle Stainier; Paul Gillard; Brigitte Cheuvart; Igor Smolenov; Eduardo Ortega-Barria; Htay Htay Han
Journal:  Vaccine       Date:  2011-10-18       Impact factor: 3.641

2.  Immune response to rotavirus vaccines among breast-fed and nonbreast-fed children.

Authors:  R I Glass; D J Ing; B J Stoll; R T Ing
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

3.  Effect of breast-feeding on seroresponse of infants to oral poliovirus vaccination.

Authors:  T J John; L V Devarajan; L Luther; P Vijayarathnam
Journal:  Pediatrics       Date:  1976-01       Impact factor: 7.124

4.  Effect of breast-feeding on oral rhesus rotavirus vaccine seroconversion: a metaanalysis.

Authors:  M E Pichichero
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

Review 5.  2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis.

Authors:  Jacqueline E Tate; Anthony H Burton; Cynthia Boschi-Pinto; A Duncan Steele; Jazmin Duque; Umesh D Parashar
Journal:  Lancet Infect Dis       Date:  2011-10-24       Impact factor: 25.071

6.  Anticipating rotavirus vaccines: epidemiology and surveillance of rotavirus in South Africa.

Authors:  A D Steele; I Peenze; M C de Beer; C T Pager; J Yeats; N Potgieter; U Ramsaroop; N A Page; J O Mitchell; A Geyer; P Bos; J J Alexander
Journal:  Vaccine       Date:  2003-01-17       Impact factor: 3.641

7.  Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries.

Authors:  Sung-Sil Moon; Jacqueline E Tate; Pratima Ray; Penelope H Dennehy; Derseree Archary; Anna Coutsoudis; Ruth Bland; Marie-Louise Newell; Roger I Glass; Umesh Parashar; Baoming Jiang
Journal:  Pediatr Infect Dis J       Date:  2013-08       Impact factor: 2.129

Review 8.  A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy.

Authors:  Manish Patel; Roger I Glass; Baoming Jiang; Mathuram Santosham; Ben Lopman; Umesh Parashar
Journal:  J Infect Dis       Date:  2013-04-17       Impact factor: 5.226

9.  Rotavirus-specific breast milk antibody in two populations and possible correlates of interference with rhesus rotavirus vaccine seroconversion.

Authors:  H C Rimer; S S Wasserman; J Flores; M E Pichichero; G A Losonsky
Journal:  J Infect Dis       Date:  1992-05       Impact factor: 5.226

10.  Rotavirus-inhibitory activity in serial milk samples from Mexican women and rotavirus infections in their children during their first year of life.

Authors:  H Brüssow; O Benitez; F Uribe; J Sidoti; K Rosa; A Cravioto
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

View more
  40 in total

Review 1.  Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.

Authors:  Olufemi Samuel Folorunso; Olihile M Sebolai
Journal:  Vaccines (Basel)       Date:  2020-06-27

Review 2.  Factors That Influence the Immune Response to Vaccination.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2019-03-13       Impact factor: 26.132

3.  Immune predictors of oral poliovirus vaccine immunogenicity among infants in South India.

Authors:  Nicholas C Grassly; Holm H Uhlig; Sudhir Babji; Punithavathy Manickavasagam; Yin-Huai Chen; Nithya Jeyavelu; Nisha Vincy Jose; Ira Praharaj; Chanduni Syed; Saravanakumar Puthupalayam Kaliappan; Jacob John; Sidhartha Giri; Srinivasan Venugopal; Beate Kampmann; Edward P K Parker; Miren Iturriza-Gómara; Gagandeep Kang
Journal:  NPJ Vaccines       Date:  2020-03-23       Impact factor: 7.344

Review 4.  Contribution of Maternal Immunity to Decreased Rotavirus Vaccine Performance in Low- and Middle-Income Countries.

Authors:  Katayi Mwila; Roma Chilengi; Michelo Simuyandi; Sallie R Permar; Sylvia Becker-Dreps
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

5.  Rotavirus-specific IgG antibodies from mothers' serum may inhibit infant immune responses to the pentavalent rotavirus vaccine.

Authors:  Sylvia Becker-Dreps; Samuel Vilchez; Daniel Velasquez; Sung-Sil Moon; Michael G Hudgens; Luis Enrique Zambrana; Baoming Jiang
Journal:  Pediatr Infect Dis J       Date:  2015-01       Impact factor: 2.129

6.  Monitoring Shedding of Five Genotypes of RotaTeq Vaccine Viruses by Genotype-Specific Real-Time Reverse Transcription-PCR Assays.

Authors:  Yuki Higashimoto; Masaru Ihira; Yu Miyazaki; Ayumi Kuboshiki; Sayaka Yoshinaga; Hiroyuki Hiramatsu; Ryota Suzuki; Masafumi Miyata; Hiroki Miura; Satoshi Komoto; Jun Yukitake; Koki Taniguchi; Yoshiki Kawamura; Tetsushi Yoshikawa
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

7.  Rotavirus vaccines: current global impact and future perspectives.

Authors:  Eleanor Burnett; Catherine Yen; Jacqueline E Tate; Umesh D Parashar
Journal:  Future Virol       Date:  2016-10       Impact factor: 1.831

Review 8.  Probiotics, antibiotics and the immune responses to vaccines.

Authors:  Ira Praharaj; Sushil M John; Rini Bandyopadhyay; Gagandeep Kang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-19       Impact factor: 6.237

9.  Rotavirus antigen, cytokine, and neutralising antibody profiles in sera of children with and without HIV infection in Blantyre, Malawi.

Authors:  Jennifer J Hull; Nigel Cunliffe; Khuzwayo C Jere; Sung-Sil Moon; Yuhuan Wang; Umesh Parashar; Baoming Jiang
Journal:  Malawi Med J       Date:  2017-03       Impact factor: 0.875

10.  Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines.

Authors:  N Aliabadi; J E Tate; U D Parashar
Journal:  Clin Microbiol Infect       Date:  2016-04-26       Impact factor: 8.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.